# Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis

> **NCT06604910** · NA · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Muscle Loss

## Interventions

- **DIETARY_SUPPLEMENT:** branched chained amino acid

## Key facts

- **NCT ID:** NCT06604910
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-25
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06604910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06604910, "Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06604910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*